Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Adma Biologics (ADMA) Return on Assets (2016 - 2025)

Adma Biologics' Return on Assets history spans 14 years, with the latest figure at 0.25% for Q4 2025.

  • For Q4 2025, Return on Assets fell 20.0% year-over-year to 0.25%; the TTM value through Dec 2025 reached 0.25%, down 20.0%, while the annual FY2025 figure was 0.26%, 22.0% down from the prior year.
  • Return on Assets reached 0.25% in Q4 2025 per ADMA's latest filing, down from 0.37% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.45% in Q4 2024 to a low of 0.33% in Q1 2021.
  • Average Return on Assets over 5 years is 0.0%, with a median of 0.09% recorded in 2023.
  • Peak YoY movement for Return on Assets: surged 45bps in 2024, then dropped -20bps in 2025.
  • A 5-year view of Return on Assets shows it stood at 0.28% in 2021, then soared by 35bps to 0.18% in 2022, then skyrocketed by 100bps to 0.0% in 2023, then soared by 15246124bps to 0.45% in 2024, then crashed by -45bps to 0.25% in 2025.
  • Per Business Quant, the three most recent readings for ADMA's Return on Assets are 0.25% (Q4 2025), 0.37% (Q3 2025), and 0.39% (Q2 2025).